Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease
Clinical trial NCT07029958 · RECRUITING
Trial details
- NCT number
- NCT07029958
- Sponsor
- Beijing Children's Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2029-10-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.